[CURRENT REPORT FOR ISSUERS SUBJECT TO THE Amendment No. 3 to FORM 8-K CURRENT REPORT July 3, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041]
[CURRENT REPORT FOR ISSUERS SUBJECT TO THE Amendment No. 3 to FORM 8-K CURRENT REPORT July 3, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041]
[ANNOUNCEMENT APPROVAL OF DIRECTORS QUALIFICATION BY CHINA INSURANCE Company Reference is made to the announcement of China Life Insurance Company Limited ( the CIRC Please refer to the circular of the annual general meeting of the Company dated 10 April 2014 for the biographical details of Mr. Su Hengxuan and Mr. Miao Ping. By Order of the Board China Life] [Description 99.1 Announcement, dated July 8, 2014 China Life Insurance Company Limited]
